Cartherics
Cartherics is a biotechnology company developing immune cell therapies for cancer and other diseases. Its lead product, CTH-401, is a natural killer (NK) cell therapy targeting ovarian cancer, currently in pre-clinical stages. The company's platform uses iPSCs generated from donated cord blood to create allogeneic cell therapies.
Funding Round: Private Financing
Funding Amount: AUD$15M
Date: 30-Sep-2024
Investors:
Markets: Biotechnology, Cell Therapy, Immunotherapy, Oncology
HQ: Notting Hill, Victoria, Australia
Founded: 2014
Website: https://cartherics.com/
LinkedIn: https://www.linkedin.com/company/cartherics-pty-ltd
Twitter: https://twitter.com/cartherics
Crunchbase: https://www.crunchbase.com/organization/cartherics
Leave a Comment
Comments
No comments yet.